Switch View
© Newsfile
10.11.2025
ISIN: CA57384M1077
Marvel Biosciences Corp.
MRVL
LISTED
TSX
Marvel Biosciences Announces Grant of Deferred Share Units
News Preview
Calgary, Alberta--(Newsfile Corp. - November 10, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), announces the award of 35,697 deferred share units ("DSUs") to Marvel's three independent directors, in lieu of cash payment for directors' fees.The DSUs...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US89422G1076
Travere Therapeutics Inc
TVTX
LISTED
NASDAQ
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on November 10, 2025, the Compensation Committee of its Board of Directors granted inducement equity grants to three new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 25,700 shares of its common stock. These inducement RSUs are subject to...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: CA25380E1060
Digicann Ventures Inc.
DCNN
LISTED
CSE
CSE Bulletin: Resumption and Symbol Change - Inactive Designation - Digicann Ventures Inc. (DCNN)
News Preview
Toronto, Ontario--(Newsfile Corp. - Le 10 novembre/November 2025) - Digicann Ventures Ltd. (the “Issuer”) has announced a termination, settlement and release agreement with 3Win Corp. and D-3 Merger Sub Inc. to mutually terminate the business combination agreement dated Sept. 27, 2024. The Exchange has determine...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
10.11.2025
ISIN: US4834971032
Kalvista Pharmaceuticals Inc
KALV
LISTED
NASDAQ
KalVista Pharmaceuticals Provides Operational Update and Reports Third Quarter Financial Results
News Preview
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today provided an operational update and reported financial results for the third quarter ended September 30, 2025.
“The US launch of EKTERLY is progressing with significant momentum, driven by strong early demand and rapid adoption among physicians and people living with HAE. We continue to see enc...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
10.11.2025
ISIN: US45685K1025
InfuSystem Holdings Inc
INFU
LISTED
XASE
InfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025
News Preview
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”),a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today Carrie Lachance, President and Chief Executive Officer and Barry Steele, Chief Financial Officer, will p...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US20603L1026
Concentra Group Holdings Parent, Inc.
CON
LISTED
NASDAQ
Concentra Appoints Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer
News Preview
Concentra®, (NYSE: CON) the nation’s largest provider of occupational health services, today announced the appointment of Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer. In this role, he will ensure Concentra’s data strategy and governance, technology enablement, and insight generation are aligned with enterprise growth...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US04546C2052
Assertio Holdings Inc
ASRT
LISTED
NASDAQ
Assertio Reports Third Quarter 2025 Financial Results
News Preview
Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs, today reported financial results for the third quarter ended September 30, 2025.
Mark Reisenauer, Chief Executive Officer, stated: “In the...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US85209E1091
Spruce Biosciences Inc
SPRB
LISTED
OTC
Spruce Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
News Preview
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today reported financial results for the third quarter ended September 30, 2025 and provided corporate updates.
“We have made significant progres...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US62857J2015
Myomo, Inc.
MYO
LISTED
XASE
Myomo Reports Third Quarter 2025 Financial and Operating Results
News Preview
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and nine months ended September 30, 2025.
“Third quarter revenues were at the high end of our...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US2560861096
DocGo Inc
DCGO
LISTED
NASDAQ
DocGo Announces Third Quarter 2025 Results
News Preview
DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended September 30, 2025.
Third Quarter 2025 Financial Highlights
Total revenue for the third quarter of 2025 was $70.8 million, compa...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US22053A1079
Quince Therapeutics Inc
CRTX
LISTED
NASDAQ
Quince Therapeutics Announces Positive iDSMB Review for eDSP in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia
News Preview
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced the positive outcome of its pre-planned safety analysis conducted by an independent data and safety monitoring board (iDSMB) for the company’s ongoing pivotal P...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US03969T1097
Arcturus Therapeutics Holdings Inc
ARCT
LISTED
NASDAQ
Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress
News Preview
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics and infectious disease vaccines, today announced its financial results for the third quarter ended September 30, 2025, and provided corporate updat...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
10.11.2025
ISIN: US98401F1057
Xencor Inc
XNCR
LISTED
NASDAQ
Xencor to Participate at Upcoming Investor Conferences
News Preview
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced that company management will participate at multiple upcoming investor conferences:
TD Cowen Immunology and Inflammation Virtual Summit
Date: Wednesday, November 12, 2025
P...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US74766Q1013
Quanterix Corp
QTRX
LISTED
NASDAQ
Quanterix Releases Financial Results for the Third Quarter of 2025
News Preview
Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced financial results for the third quarter ended September 30, 2025.
“During the third quarter, we delivered on our revenue expectations despite challenging market conditions,” said Masoud To...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN INSPIRE MEDICAL SYSTEMS, INC. (INSP), CONTACT THE LAW OFFICES OF HOWARD G....
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
Ongoing Securities Investigation into Molina Healthcare, Inc. (MOH) - Contact Levi & Korsinsky
News Preview
New York, New York--(Newsfile Corp. - November 10, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Molina Healthcare, Inc. ("Molina Healthcare, Inc.") (NYSE: MOH) concerning possible violations of federal securities laws.On October 23, 2025, Molina published its third quarter, fiscal 2025 earnings well belo...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Securities Lawsuit Alert: Inspire Medical Systems, Inc. (INSP) Investors - Contact Levi & Korsinsky Before January 5, 2026
News Preview
New York, New York--(Newsfile Corp. - November 10, 2025) - If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE: INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/inspire-medical-systems-inc-lawsuit-submission-form?prid=17...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US22663K1079
Crinetics Pharmaceuticals Inc
CRNX
LISTED
NASDAQ
Crinetics Pharmaceuticals Announces November 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on November 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 37,675 shares of its common stock and granted an aggregate of 25,300 restricted stock unit...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US68572M1062
Orchestra Biomed Holdings Inc
OBIO
LISTED
NASDAQ
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
News Preview
NEW HOPE, Pa., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced financial results for the third quarter ended September 30, 2025, and provided a busi...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US8257041090
SI-BONE Inc
SIBN
LISTED
NASDAQ
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance
News Preview
Delivered ~21% worldwide revenue growth, ~5% adjusted EBITDA margin, and positive cash from operating activities in the quarter...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US98943L1070
Zentalis Pharmaceuticals Inc
ZNTL
LISTED
NASDAQ
Zentalis Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Progress
News Preview
DENALI Phase 2 trial evaluating azenosertib in patients with Cyclin E1-positive PROC remains on track with topline data anticipated by year end 2026, with the potential to support an accelerated approval, subject to FDA feedback...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US6031701013
Mineralys Therapeutics Inc
MLYS
LISTED
NASDAQ
Mineralys Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
News Preview
– Submission of New Drug Application (NDA) for lorundrostat planned for late-2025/Q1 2026 –...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Deadline Alert: Avantor, Inc. (AVTR) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming December 29, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) common stock between March 5, 2024 and October 28, 2025, inclusive (the “Class Peri...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US8753722037
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
ROSEN, A LEADING LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
News Preview
New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued materially misleading business inform...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
News Preview
New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"). A class action lawsuit ha...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - MLTX
News Preview
New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both dates inclusive (the "Class Period"), of the important December 15, 2025 lead plaintiff deadline....
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Securities Fraud Investigation Into Inspire Medical Systems, Inc. (INSP) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON INSPIRE MEDICAL SYSTEMS, INC. (INSP), CLICK HERE TO INQUIRE ABOUT POTENTIAL...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: FR0004065605
Medincell S.A.
MEDCL
LISTED
EURONEXT
Medincell to Join MSCI World Small Cap Index, a Leading Global Benchmark
News Preview
Medincell has been selected for inclusion in the Morgan Stanley Capital International (MSCI) World Small Cap Index, which encompasses the most liquid and high-performing small-cap companies across 23 developed markets.
Joining the MSCI World Small Cap Index reflects the strength of Medincell’s business model, its growth potential, and its commit...
Themefolio
Profiler
Peergroup
© EQS Newswire
10.11.2025
ISIN: CH0360674466
Galenica AG
GALE
LISTED
SIX
Galenica platziert erfolgreich Anleihe über CHF 250 Millionen
News Preview
Galenica AG
/ Schlagwort(e): Anleihe
Galenica platziert erfolgreich Anleihe über CHF 250 Millionen 10.11.2025 / 17:55 CET/CEST
Medienmitteilung
Galenica hat heute erfolgreich eine festverzinsliche Anleihe über CHF 250 Mio. platziert. Die Anleihe hat eine Laufzeit von 7 Jahren und einen jährlichen Coupon von 1.08%. Der Erlös de......
Themefolio
Profiler
Peergroup
© EQS Newswire
10.11.2025
ISIN: CH0360674466
Galenica AG
GALE
LISTED
SIX
Galenica successfully places a bond of over CHF 250 million
News Preview
Galenica AG
/ Key word(s): Bond
Galenica successfully places a bond of over CHF 250 million 10.11.2025 / 17:55 CET/CEST
Press release
Today, Galenica successfully placed a fixed rate bond of over CHF 250 million. The bond has a term of 7 years and an annual coupon of 1.08%. The proceeds from the transaction will be used to rep......
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US00404A1097
Acadia Healthcare Company Inc
ACHC
LISTED
NASDAQ
Acadia Healthcare to Participate in UBS 2025 Global Healthcare Conference
News Preview
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in a fireside chat at the UBS Global Healthcare Conference, November 9 - 12, 2025, in Palm Beach Gardens, Florida.
In connection with the conference, there will be an online webcast of the Company’s presentation available on the Company’s website sta...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Lantheus Investors Have Opportunity to Lead Class Action Lawsuit
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH) and reminds investors of the November 10, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
F...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: FR0014000MR3
Eurofins Scientific SE
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF T...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: DK0010272202
Genmab A/S
GMAB
LISTED
CPH
Genmab Provides Certain Information Disclosed in Connection with Proposed Private Offering of Senior Secured Notes and Senior Unsecured Notes
News Preview
Media Release...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
Lost Money on MoonLake Immunotherapeutics (MLTX)? Urged to Join Class Action Before December 15, 2025 - Contact Levi & Korsinsky
News Preview
New York, New York--(Newsfile Corp. - November 10, 2025) - If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ: MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/moonlake-lawsuit-submission-form?prid=176446&wire=5&...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US71535D1063
Personalis, Inc.
PSNL
LISTED
NASDAQ
Personalis Announces Medicare Coverage for Ultrasensitive MRD Test in Breast Cancer
News Preview
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced Medicare coverage of its ultrasensitive NeXT Personal® test for surveillance of cancer recurrence in breast cancer patients. This milestone marks an important step forward in cancer surveillance, offering a powerful tool for doctors and breast ca...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: CA00288U1066
Abcellera Biologics Inc
ABCL
LISTED
NASDAQ
AbCellera Appoints Dr. Stephen Quake to its Board of Directors
News Preview
AbCellera (Nasdaq: ABCL) today announced the appointment of Stephen Quake, D.Phil., to its Board of Directors as an independent director.
Dr. Quake is a distinguished scientist, inventor, and entrepreneur who has made foundational contributions across diverse fields, including single molecule biophysics, microfluidics, single cell analysis, genom...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Levi & Korsinsky Notifies Avantor, Inc. (AVTR) Investors - Lead Plaintiff Deadline on December 29, 2025
News Preview
New York, New York--(Newsfile Corp. - November 10, 2025) - If you suffered a loss on your Avantor, Inc. (NYSE: AVTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/avantor-inc-lawsuit-submission-form?prid=176444&wire=5&utm_campaign...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US8753722037
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
Tandem Mobi Receives FDA Clearance for Use with Android Smartphones
News Preview
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Android version of the Tandem Mobi mobile app.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202511107994...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Lost Money on Baxter International, Inc. (BAX)? Join Class Action Before December 15, 2025 - Contact Levi & Korsinsky
News Preview
New York, New York--(Newsfile Corp. - November 10, 2025) - If you suffered a loss on your Baxter International, Inc. (NYSE: BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-form?prid=176438...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US1404752032
Sonida Senior Living Inc
SNDA
LISTED
NYSE
Sonida Senior Living Announces Third Quarter 2025 Results
News Preview
Sonida Senior Living, Inc. (the “Company,” “Sonida,” “we,” “our,” or “us”) (NYSE: SNDA), a leading owner, operator and investor of senior housing communities, today announced its results for the third quarter ended September 30, 2025.
“In the third quarter, total portfolio community NOI grew approximately 21%, driven by solid rent growth and stro...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: CA25253X2077
DiaMedica Therapeutics, Inc.
DMAC
LISTED
NASDAQ
DiaMedica Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
News Preview
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced that Rick Pauls, President and CEO, will participate in the Jefferies Global Healthcare Conference in London, taking place November 17-20...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US40131M1099
Guardant Health Inc
GH
LISTED
NASDAQ
Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring
News Preview
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the expansion of its Guardant Reveal® blood test to include late-stage therapy response monitoring for patients with solid tumors. Guardant Reveal tracks more than 20,000 epigenomic (methylation) signals to measure changes in circulating tumor DNA (ctDNA) lev...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US0327241065
AnaptysBio Inc
ANAB
LISTED
NASDAQ
Anaptys Announces Phase 2 Trial of Rosnilimab Did Not Meet Primary or Secondary Endpoints at Week 12 in Moderate-to-Severe Ulcerative Colitis
News Preview
SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that investigational rosnilimab was safe and well tolerated but did not meet the primary endpoint of mean change from baseline in modified Mayo Score (mMS) o...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US46266A1097
IRadimed Corp
IRMD
LISTED
NASDAQ
IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders for 2026
News Preview
Recognized for Exceptional Revenue Growth, Financial Stability, and Stock Performance Recognized for Exceptional Revenue Growth, Financial Stability, and Stock Performance...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US1920051067
Codexis Inc
CDXS
LISTED
NASDAQ
Codexis Announces Signing of Lease for GMP Manufacturing Facility
News Preview
REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced that it has signed a lease for a 34,000 square foot GMP manufacturing facility in Hayward, California....
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US29415V1098
Envoy Medical, Inc.
COCH
LISTED
NASDAQ
Envoy Medical Reports Third Quarter 2025 Financial and Operational Results
News Preview
Transformational quarter puts Envoy Medical in significantly better position as it eliminated $32 million of debt, strengthened its balance sheet, and further expanded its patent portfolio; In addition, subsequent to quarter end, the Company received FDA approval to expand its pivotal clinical trial to the final stage, restarted enrollment, and suc...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US3444374058
Fonar Corp
FONR
LISTED
NASDAQ
Fonar Announces Financial Results For The 1st Quarter of Fiscal 2026
News Preview
Cash and cash equivalents decreased 4% to $54.3 million at September 30, 2025 as compared to the fiscal year-ended June 30, 2025.Total Revenues - Net increased by 4% to $26.0 million for the quarter ended September 30, 2025 versus the corresponding quarter one year earlier.Income from Operations decreased 30% to $3.2 million for the quarter ended S...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
Humana Foundation Pledges $500,000 to Meet Surge in Demand for Food
News Preview
The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 44 years, today announced $500,000 in new investments to support food banks and nutrition programs in four states. The funding will help address urgent needs in communities where the loss of food assistance for nearly 42 million Americans, have intensified food in...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US87427V1035
Talkspace Inc
TALK
LISTED
NASDAQ
Talkspace Launches “Chapters” — A Comprehensive Program Supporting Women’s Mental Health Across Every Stage of Life
News Preview
Talkspace, a leading online behavioral health company, today announced the launch of Chapters by Talkspace, a new clinical program designed to address the unique mental health and wellness needs of women throughout their lifespan.
Chapters delivers tailored care across women’s life stages, offering personalized treatment pathways that adapt to in...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
Broadwood Partners Calls for the Appointment of New Directors at STAAR Surgical to Oversee Go-Shop Process
News Preview
Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today commented on the recent filing of amendments to the merger agreement in connection with the proposed sale of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) to Alcon Inc. (“Alcon”) (NYSE: ALC).
Neal C. Bradsher, Founder and President of Broadwood, said...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US89680M1018
TriSalus Life Sciences, Inc.
TLSI
LISTED
NASDAQ
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Uterine Fibroids on November 12, 2025
News Preview
TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients with solid tumors, announced today that it will host a virtual key opinion leader (KOL) event on Wednesday, November 12, 2025 at 10:00 AM ET featuri...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US14167L1035
CareDx Inc
CDNA
LISTED
NASDAQ
CareDx to Participate in Upcoming Investor Conferences
News Preview
CareDx, Inc. (Nasdaq: CDNA)- The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced the company will participate in the following investor conferences:
Stephen...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US56600D1072
Maravai LifeSciences Holdings Inc
MRVI
LISTED
NASDAQ
Maravai LifeSciences Announces November 2025 Investor Conference Schedule
News Preview
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month of November.
On November 12, 2025, at 10:00 a.m. EST, Raj Asarpota, Chief Financial Officer, will participate in a fireside chat...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US7140461093
Revvity Inc
RVTY
LISTED
NYSE
Revvity to Acquire ACD/Labs to Expand its Signals Software Capabilities
News Preview
Revvity, Inc. (NYSE: RVTY), today announced it has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software solutions that support analytical characterization and molecular design across pharmaceutical and material sciences end markets. This acquisition expands the breadth and depth of Revvity Signals’ solu...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US70465T1079
PDS Biotechnology Corp
PDSB
LISTED
NASDAQ
PDS Biotechnology Announces Translational Data Showing Strong Immunological and Clinical Activity of PDS0101 and PDS01ADC Presented at SITC 2025
News Preview
PRINCETON, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced positive clinical and translational data presented at the 2025 Society for Immunotherapy of Ca...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US62855J1043
Myriad Genetics Inc
MYGN
LISTED
NASDAQ
Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs
News Preview
Myriad Genetics expanded MyRisk® Hereditary Cancer Test to include genes referenced in national oncology guidelines....
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH INVESTOR NOTICE: Molina Healthcare, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
News Preview
San Diego, California--(Newsfile Corp. - November 10, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Molina Healthcare, Inc. (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, inclusive (the "Class Period"), have until Tuesday, December 2, 2025 to seek appointment as lead plain...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US68622V1061
Organon & Co
OGN
LISTED
NYSE
Organon Reports Results for the Third Quarter Ended September 30, 2025
News Preview
Organon (NYSE: OGN) today announced its results for the third quarter ended September 30, 2025.
“I am humbled to be working alongside our talented team during this pivotal time for Organon,” said Joe Morrissey, Organon’s Interim Chief Executive Officer. “We are harnessing the company's many strengths, including a diverse portfolio that we expect...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US81727U1051
Senseonics Holdings Inc
SENS
LISTED
XASE
Senseonics Holdings, Inc. to Participate in the Stifel 2025 Healthcare Conference
News Preview
GERMANTOWN, Md., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Stifel 2025 Healthcare Co...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
